| dc.contributor.author |
McGee, Kara S |
|
| dc.contributor.author |
Okeke, Nwora Lance |
|
| dc.contributor.author |
Hurt, Christopher B |
|
| dc.contributor.author |
McKellar, Mehri S |
|
| dc.date.accessioned |
2020-05-12T18:01:01Z |
|
| dc.date.available |
2020-05-12T18:01:01Z |
|
| dc.date.issued |
2018-11-08 |
|
| dc.identifier |
ofy294 |
|
| dc.identifier.issn |
2328-8957 |
|
| dc.identifier.issn |
2328-8957 |
|
| dc.identifier.uri |
https://hdl.handle.net/10161/20635 |
|
| dc.description.abstract |
Transmitted drug resistance to the integrase strand transfer inhibitor (INSTI) class
of antiretrovirals is very rare. We present a case of a treatment-naive female patient
with human immunodeficiency virus harboring resistance to all INSTIs, including bictegravir
and dolutegravir.
|
|
| dc.language |
eng |
|
| dc.publisher |
Oxford University Press (OUP) |
|
| dc.relation.ispartof |
Open forum infectious diseases |
|
| dc.relation.isversionof |
10.1093/ofid/ofy294 |
|
| dc.subject |
HIV |
|
| dc.subject |
integrase |
|
| dc.subject |
transmitted resistance |
|
| dc.subject |
treatment naive |
|
| dc.title |
Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase
Strand Transfer Inhibitors in a Treatment-Naive Patient.
|
|
| dc.type |
Journal article |
|
| duke.contributor.id |
McGee, Kara S|0376256 |
|
| duke.contributor.id |
Okeke, Nwora Lance|0437422 |
|
| duke.contributor.id |
McKellar, Mehri S|0488439 |
|
| dc.date.updated |
2020-05-12T18:01:00Z |
|
| pubs.begin-page |
ofy294 |
|
| pubs.issue |
11 |
|
| pubs.organisational-group |
School of Medicine |
|
| pubs.organisational-group |
Medicine, Infectious Diseases |
|
| pubs.organisational-group |
Duke |
|
| pubs.organisational-group |
Medicine |
|
| pubs.organisational-group |
Clinical Science Departments |
|
| pubs.organisational-group |
School of Nursing |
|
| pubs.publication-status |
Published |
|
| pubs.volume |
5 |
|
| duke.contributor.orcid |
McGee, Kara S|0000-0003-1560-8820 |
|
